Patient diagnosed with dementia.
Patients with serious and unstable illnesses including current hepatic, renal, gastroenterologic, respiratory, cardiovascular (including ischemic heart disease and congestive heart failure), endocrinologic, neurologic (including stroke, transient ischemic attack, subarachnoidal bleeding, brain tumor, encephalopathy, and meningitis).
Patients with a history of allergic reactions to loxapine or amoxapine
Patients who have received an investigational drug within 30 days prior to the current agitation episode must be excluded.
Patients who are considered by the investigator, for any reason, to be unable to self-administer the inhalation device.

NCT02525991_exc_T1
Condition
dementia
NCT02525991_exc_T2
Qualifier
serious
NCT02525991_exc_T3
Qualifier
unstable
NCT02525991_exc_T4
Scope
serious and unstable
NCT02525991_exc_T5
Condition
hepatic
NCT02525991_exc_T6
Condition
renal
NCT02525991_exc_T7
Condition
gastroenterologic
NCT02525991_exc_T8
Condition
respiratory
NCT02525991_exc_T9
Condition
cardiovascular
NCT02525991_exc_T10
Condition
neurologic
NCT02525991_exc_T11
Condition
endocrinologic
NCT02525991_exc_T12
Condition
ischemic heart disease
NCT02525991_exc_T13
Condition
congestive heart failure
NCT02525991_exc_T14
Condition
stroke
NCT02525991_exc_T15
Condition
transient ischemic attack
NCT02525991_exc_T16
Condition
subarachnoidal bleeding
NCT02525991_exc_T17
Condition
brain tumor
NCT02525991_exc_T18
Condition
encephalopathy
NCT02525991_exc_T19
Condition
meningitis
NCT02525991_exc_T20
Scope
stroke, transient ischemic attack, subarachnoidal bleeding, brain tumor, encephalopathy, and meningitis
NCT02525991_exc_T21
Scope
ischemic heart disease and congestive heart failure)
NCT02525991_exc_T22
Scope
hepatic, renal, gastroenterologic, respiratory, cardiovascular (including ischemic heart disease and congestive heart failure), endocrinologic, neurologic (including stroke, transient ischemic attack, subarachnoidal bleeding, brain tumor, encephalopathy, and meningitis
NCT02525991_exc_T23
Condition
allergic reactions
NCT02525991_exc_T24
Drug
loxapine
NCT02525991_exc_T25
Drug
amoxapine
NCT02525991_exc_T26
Scope
loxapine or amoxapine